Inscrição na biblioteca: Guest
Critical Reviews™ in Eukaryotic Gene Expression

Publicou 6 edições por ano

ISSN Imprimir: 1045-4403

ISSN On-line: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Ganhar acesso(open in a new tab)
Mais
Compra $35.00(open in a new tab) Verifique a assinatura Download do registro MARC(open in a new tab) Obter permissões(open in a new tab)

The Role of the Androgen Receptor in Prostate Cancer

Volume 12, Edição 3, 2002, 15 pages
DOI: 10.1615/CritRevEukaryotGeneExpr.v12.i3.30
Get accessGet access
Haojie Huang
Departments of Urology and Biochemistry/Molecular Biology, Mayo Clinic, Rochester, MN 55905
Donald J. Tindall
Departments of Urology and Biochemistry/Molecular Biology, Mayo Clinic, Rochester, MN 55905

RESUMO

Androgens are important not only for the development and function of the normal prostate gland, but also for the maintenance of prostate cancer (PCa) cells. The biological function of androgens is exerted by activation of the transcriptional activity of the androgen receptor (AR). The function of the AR in the prostate is largely dependent on AR protein levels and structural integrity of the protein and other transcription activation factors. Based upon the clinical findings that androgen ablation therapy-resistant PCa still expresses AR and the androgen-regulated gene, prostate-specific antigen, a concept is developing that the androgen receptor is critical for androgen-refractory prostate cancer cells. Indeed, because of the alterations detected in the AR gene, many noncognate activators, including estrogen, progesterone, peptide growth factors, and cytokines, are able to induce transactivation of the AR under androgen-depleted conditions. Also, transactivational activity of the AR is often modulated by crosstalk between the AR and other signaling pathways in cancerous prostatic cells. Dysregulation of AR function in prostate cancer results in an abnormal profile of AR-regulated genes, which include cell cycle regulators, transcription factors, and those proteins important for cell survival, lipogenesis, and secretion. Thus in this review we will evaluate the significance of the AR in the development and progression of prostate cancer.

CITADO POR

  1. Weber Michael J., Gioeli Daniel, Ras signaling in prostate cancer progression, Journal of Cellular Biochemistry, 91, 1, 2004. Crossref

  2. Wang Thomas T. Y., Schoene Norberta W., Kim Young S., Mizuno Cassia S., Rimando Agnes M., Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells, Molecular Nutrition & Food Research, 54, 3, 2010. Crossref

  3. Xiao Wuhan, Jiang Feng, Wang Zhou, ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation, The Prostate, 66, 1, 2006. Crossref

  4. Nelius Thomas, Filleur Stephanie, Yemelyanov Alexander, Budunova Irina, Shroff E., Mirochnik Yelena, Aurora Arin, Veliceasa Dorina, Xiao Wuhan, Wang Zhou, Volpert Olga V., Androgen receptor targets NFκB and TSP1 to suppress prostate tumor growthin vivo, International Journal of Cancer, 121, 5, 2007. Crossref

  5. Takahashi Yoko, Hursting Stephen D., Perkins Susan N., Wang Tien-Chung, Wang Thomas T.Y., Genistein affects androgen-responsive genes through both androgen- and estrogen-induced signaling pathways, Molecular Carcinogenesis, 45, 1, 2006. Crossref

  6. Kaur Manjinder, Velmurugan Balaiya, Rajamanickam Subapriya, Agarwal Rajesh, Agarwal Chapla, Gallic Acid, an Active Constituent of Grape Seed Extract, Exhibits Anti-proliferative, Pro-apoptotic and Anti-tumorigenic Effects Against Prostate Carcinoma Xenograft Growth in Nude Mice, Pharmaceutical Research, 26, 9, 2009. Crossref

  7. Wang T. T.Y., Hudson T. S., Wang T.-C., Remsberg C. M., Davies N. M., Takahashi Y., Kim Y. S., Seifried H., Vinyard B. T., Perkins S. N., Hursting S. D., Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo, Carcinogenesis, 29, 10, 2008. Crossref

  8. Bostwick David G., Burke Harry B., Djakiew Daniel, Euling Susan, Ho Shuk-mei, Landolph Joseph, Morrison Howard, Sonawane Babasaheb, Shifflett Tiffany, Waters David J., Timms Barry, Human prostate cancer risk factors, Cancer, 101, S10, 2004. Crossref

  9. Simon Stephanie, Mueller Stefan O., Human reporter gene assays: Transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context, Toxicology, 220, 2-3, 2006. Crossref

  10. Platz Elizabeth A., Giovannucci Edward, The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer, The Journal of Steroid Biochemistry and Molecular Biology, 92, 4, 2004. Crossref

  11. LEIBOVITZ ARTHUR, BAUMOEHL YEHUDA, SEGAL RAFAEL, INCREASED INCIDENCE OF PATHOLOGICAL AND CLINICAL PROSTATE CANCER WITH AGE: AGE RELATED ALTERATIONS OF LOCAL IMMUNE SURVEILLANCE, Journal of Urology, 172, 2, 2004. Crossref

  12. Locke Jennifer A., Nelson Colleen C., Adomat Hans H., Hendy Stephen C., Gleave Martin E., Guns Emma S. Tomlinson, Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts, The Journal of Steroid Biochemistry and Molecular Biology, 115, 3-5, 2009. Crossref

  13. Swinnen Johannes V., Heemers Hannelore, de Sande Tine Van, Schrijver Ellen De, Brusselmans Koen, Heyns Walter, Verhoeven Guido, Androgens, lipogenesis and prostate cancer, The Journal of Steroid Biochemistry and Molecular Biology, 92, 4, 2004. Crossref

  14. Srinivas Sandy, Krishnan Aruna V., Colocci Natalia, Feldman David, Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer, Urology, 67, 5, 2006. Crossref

  15. Masuda Katsuaki, Werner Thomas, Maheshwari Shilpi, Frisch Matthias, Oh Soyon, Petrovics Gyorgy, May Klaus, Srikantan Vasantha, Srivastava Shiv, Dobi Albert, Androgen Receptor Binding Sites Identified by a GREF_GATA Model, Journal of Molecular Biology, 353, 4, 2005. Crossref

  16. Folkertsma Simon, van Noort Paula, Van Durme Joost, Joosten Henk-Jan, Bettler Emmanuel, Fleuren Wilco, Oliveira Laerte, Horn Florence, de Vlieg Jacob, Vriend Gerrit, A Family-based Approach Reveals the Function of Residues in the Nuclear Receptor Ligand-binding Domain, Journal of Molecular Biology, 341, 2, 2004. Crossref

  17. Tsai Chih-Cheng, Fondell Joseph D, Nuclear Receptor Recruitment of Histone-Modifying Enzymes to Target Gene Promoters, in Nuclear Receptor Coregulators, 68, 2004. Crossref

  18. Bohrer Laura R., Liu Ping, Zhong Jian, Pan Yunqian, Angstman James, Brand Lucas J., Dehm Scott M., Huang Haojie, FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants, The Prostate, 73, 10, 2013. Crossref

  19. Zaveri N.T., Murphy B.J., Nuclear Hormone Receptors, in Comprehensive Medicinal Chemistry II, 2007. Crossref

  20. Liu Ze-Jun, Wang Gang, Cai Yun, Gu Shou-Zhi, Zhang Xiao-Bing, Liu Li, Gao Xing, Androgen Receptor CpG Island Methylation Status in Human Leukemia Cancer Cells, Cancer Investigation, 27, 2, 2009. Crossref

  21. Mimeault Murielle, Pommery Nicole, Hénichart Jean-Pierre, New Advances on Prostate Carcinogenesis and Therapies: Involvement of EGF-EGFR Transduction System, Growth Factors, 21, 1, 2003. Crossref

  22. Choi Hye-Eun, Shin Ji-Sun, Leem Dong-Gyu, Kim Soo-Dong, Cho Won-Jea, Lee Kyung-Tae, 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells, Chemico-Biological Interactions, 260, 2016. Crossref

  23. Chen Guangchun, Nomura Masatoshi, Morinaga Hidetaka, Matsubara Eri, Okabe Taijiro, Goto Kiminobu, Yanase Toshihiko, Zheng Hong, Lu Jian, Nawata Hajime, Modulation of Androgen Receptor Transactivation by FoxH1, Journal of Biological Chemistry, 280, 43, 2005. Crossref

  24. Jasavala Rohini, Martinez Harryl, Thumar Jaykumar, Andaya Armann, Gingras Anne-Claude, Eng Jimmy K., Aebersold Ruedi, Han David K., Wright Michael E., Identification of Putative Androgen Receptor Interaction Protein Modules, Molecular & Cellular Proteomics, 6, 2, 2007. Crossref

  25. Turanli Beste, Gulfidan Gizem, Arga Kazim Yalcin, Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma, OMICS: A Journal of Integrative Biology, 21, 10, 2017. Crossref

  26. Khurana Namrata, Sikka Suresh, Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer, Cancers, 10, 10, 2018. Crossref

  27. Lee Jiyeong, Mun Sora, Park Arum, Kim Doojin, Heun Cha Byung, Kang Hee-Gyoo, Bicalutamide enhances fodrin-mediated apoptosis through calpain in LNCaP, Experimental Biology and Medicine, 243, 10, 2018. Crossref

  28. Huang Haojie, Androgen Regulation of the Cell Cycle in Prostate Cancer, in Androgen-Responsive Genes in Prostate Cancer, 2013. Crossref

  29. Hayashida Tetsu, Gupta Vandana, Thiagalingam Sam, Maheswaran Shyamala, Activins, Inhibins, and Bone Morphogenetic Proteins as Modulators and Biomarkers of Prostate Cancer Progression, in Transforming Growth Factor-β in Cancer Therapy, Volume I, 2008. Crossref

  30. Khurana Namrata, Sikka Suresh C., Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer, International Journal of Molecular Sciences, 20, 9, 2019. Crossref

  31. Jiang Mei, Ma Yunsheng, Chen Congcong, Fu Xuping, Yang Shu, Li Xia, Yu Guohua, Mao Yumin, Xie Yi, Li Yao, Androgen-Responsive Gene Database: Integrated Knowledge on Androgen-Responsive Genes, Molecular Endocrinology, 23, 11, 2009. Crossref

  32. Cao Subing, Ma Tianfang, Ungerleider Nathan, Roberts Claire, Kobelski Margaret, Jin Lianjin, Concha Monica, Wang Xia, Baddoo Melody, Nguyen Holly M., Corey Eva, Fazli Ladan, Ledet Elisa, Zhang Rubin, Silberstein Jonathan L., Zhang Wensheng, Zhang Kun, Sartor Oliver, Dong Xuesen, Flemington Erik K., Dong Yan, Circular RNAs add diversity to androgen receptor isoform repertoire in castration-resistant prostate cancer, Oncogene, 38, 45, 2019. Crossref

  33. Powzaniuk Mark, McElwee-Witmer Sheila, Vogel Robert L., Hayami Tadashi, Rutledge Su Jane, Chen Fang, Harada Shun-ichi, Schmidt Azriel, Rodan Gideon A., Freedman Leonard P., Bai Chang, The LATS2/KPM Tumor Suppressor Is a Negative Regulator of the Androgen Receptor, Molecular Endocrinology, 18, 8, 2004. Crossref

  34. Helenius Merja A., Waltering Kati K., Visakorpi Tapio, Somatic Genetic Changes in Prostate Cancer, in Prostate Cancer, 2008. Crossref

  35. Jaganathan Anbalagan, Chaurasia Pratima, Xiao Guang-Qian, Philizaire Marc, Lv Xiang, Yao Shen, Burnstein Kerry L., Liu De-Pei, Levine Alice C., Mujtaba Shiraz, Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer Cells, Molecular Endocrinology, 28, 6, 2014. Crossref

  36. Hoang David T., Iczkowski Kenneth A., Kilari Deepak, See William, Nevalainen Marja T., Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles, Oncotarget, 8, 2, 2017. Crossref

  37. Abd. Wahab Nurul Azwa, H. Lajis Nordin, Abas Faridah, Othman Iekhsan, Naidu Rakesh, Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer, Nutrients, 12, 3, 2020. Crossref

  38. Chan Alanna B., Lamia Katja A., Cancer, hear my battle CRY, Journal of Pineal Research, 69, 1, 2020. Crossref

  39. Shah Kalpit, Bradbury Neil A., Lemur Tyrosine Kinase 2, a novel target in prostate cancer therapy, Oncotarget, 6, 16, 2015. Crossref

  40. Bohrer Laura R., Chen Shuai, Hallstrom Timothy C., Huang Haojie, Androgens Suppress EZH2 Expression Via Retinoblastoma (RB) and p130-Dependent Pathways: A Potential Mechanism of Androgen-Refractory Progression of Prostate Cancer, Endocrinology, 151, 11, 2010. Crossref

  41. Lyons Leah S., Rao Shuyun, Balkan Wayne, Faysal Joanne, Maiorino Carol A., Burnstein Kerry L., Ligand-Independent Activation of Androgen Receptors by Rho GTPase Signaling in Prostate Cancer, Molecular Endocrinology, 22, 3, 2008. Crossref

  42. Yang Jian, Wei Shuo, Wang Da-Sheng, Wang Yu-Chieh, Kulp Samuel K., Chen Ching-Shih, Pharmacological Exploitation of the Peroxisome Proliferator-Activated Receptor γ Agonist Ciglitazone To Develop a Novel Class of Androgen Receptor-Ablative Agents, Journal of Medicinal Chemistry, 51, 7, 2008. Crossref

  43. Shah Kalpit, Gagliano Teresa, Garland Lisa, O’Hanlon Timothy, Bortolotti Daria, Gentili Valentina, Rizzo Roberta, Giamas Georgios, Dean Michael, Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing, Oncogene, 39, 39, 2020. Crossref

  44. Xu Tianwei, Wang Mengwei, Jiang Lihua, Ma Li, Wan Li, Chen Qinnan, Wei Chenchen, Wang Zhaoxia, CircRNAs in anticancer drug resistance: recent advances and future potential, Molecular Cancer, 19, 1, 2020. Crossref

  45. Lange Carol A., Gioeli Daniel, Hammes Stephen R., Marker Paul C., Integration of Rapid Signaling Events with Steroid Hormone Receptor Action in Breast and Prostate Cancer, Annual Review of Physiology, 69, 1, 2007. Crossref

  46. Vona Rosa, Iessi Elisabetta, Matarrese Paola, Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?, Frontiers in Cell and Developmental Biology, 9, 2021. Crossref

  47. Hwang Dong-Jin, He Yali, Ponnusamy Suriyan, Mohler Michael L., Thiyagarajan Thirumagal, McEwan Iain J., Narayanan Ramesh, Miller Duane D., New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity, Journal of Medicinal Chemistry, 62, 2, 2019. Crossref

  48. Ai Ni, DeLisle Robert K., Yu Seong Jae, Welsh William J., Computational Models for Predicting the Binding Affinities of Ligands for the Wild-Type Androgen Receptor and a Mutated Variant Associated with Human Prostate Cancer, Chemical Research in Toxicology, 16, 12, 2003. Crossref

  49. Ma Tianfang, Bai Shanshan, Qi Yanfeng, Zhan Yang, Ungerleider Nathan, Zhang Derek Y., Neklesa Taavi, Corey Eva, Dehm Scott M., Zhang Kun, Flemington Erik K., Dong Yan, Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapy, Cancer Letters, 504, 2021. Crossref

  50. GIOELI Daniel, Signal transduction in prostate cancer progression, Clinical Science, 108, 4, 2005. Crossref

  51. Locke Jennifer A., Guns Emma S., Lubik Amy A., Adomat Hans H., Hendy Stephen C., Wood Catherine A., Ettinger Susan L., Gleave Martin E., Nelson Colleen C., Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer, Cancer Research, 68, 15, 2008. Crossref

  52. Peng Yi, Chen Fei, Melamed Jonathan, Chiriboga Luis, Wei Jianjun, Kong Xiangtian, Mcleod Maureen, Li Yirong, Li Caihong X., Feng Alice, Garabedian Michael J., Wang Zhengxin, Roeder Robert G., Lee Peng, Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer, Proceedings of the National Academy of Sciences, 105, 13, 2008. Crossref

  53. Gogia Neha, Ni Luhan, Olmos Victor, Haidery Fatema, Luttik Kimberly, Lim Janghoo, Exploring the Role of Posttranslational Modifications in Spinal and Bulbar Muscular Atrophy, Frontiers in Molecular Neuroscience, 15, 2022. Crossref

  54. Sun Tong, Lee Gwo-Shu Mary, Werner Lillian, Pomerantz Mark, Oh William K., Kantoff Philip W., Freedman Matthew L., Inherited Variations in AR, ESR1, and ESR2 Genes Are Not Associated With Prostate Cancer Aggressiveness or With Efficacy of Androgen Deprivation Therapy, Cancer Epidemiology, Biomarkers & Prevention, 19, 7, 2010. Crossref

  55. Yang Chun-Song, Vitto Michael J., Busby Scott A., Garcia Benjamin A., Kesler Cristina T., Gioeli Daniel, Shabanowitz Jeffrey, Hunt Donald F., Rundell Kathleen, Brautigan David L., Paschal Bryce M., Simian Virus 40 Small t Antigen Mediates Conformation-Dependent Transfer of Protein Phosphatase 2A onto the Androgen Receptor, Molecular and Cellular Biology, 25, 4, 2005. Crossref

  56. Yang Chih-Cheng, Wang Yu-Chieh, Wei Shuo, Lin Li-Fang, Chen Chang-Shi, Lee Cheng-Chun, Lin Cheng-Chieh, Chen Ching-Shih, Peroxisome Proliferator-Activated Receptor γ–Independent Suppression of Androgen Receptor Expression by Troglitazone Mechanism and Pharmacologic Exploitation, Cancer Research, 67, 7, 2007. Crossref

  57. Wu Jennifer D., Odman Austin, Higgins Lily M., Haugk Kathy, Vessella Robert, Ludwig Dale L., Plymate Stephen R., In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate Tumors, Clinical Cancer Research, 11, 8, 2005. Crossref

  58. Lim Jin T. E., Mansukhani Mahesh, Weinstein I. Bernard, Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells, Proceedings of the National Academy of Sciences, 102, 14, 2005. Crossref

  59. Liu Ping, Li Shangwei, Gan Lu, Kao Timothy P., Huang Haojie, A Transcription-Independent Function of FOXO1 in Inhibition of Androgen-Independent Activation of the Androgen Receptor in Prostate Cancer Cells, Cancer Research, 68, 24, 2008. Crossref

  60. Bonham Michael, Posakony Jeff, Coleman Ilsa, Montgomery Bruce, Simon Julian, Nelson Peter S., Characterization of Chemical Constituents in Scutellaria baicalensis with Antiandrogenic and Growth-Inhibitory Activities toward Prostate Carcinoma, Clinical Cancer Research, 11, 10, 2005. Crossref

  61. Huang Haojie, Zegarra-Moro Ofelia L, Benson Douglas, Tindall Donald J, Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells, Oncogene, 23, 12, 2004. Crossref

1843 Visualizações do artigo 24 downloads de artigos Métricas
1843 VISUALIZAÇÕES 24 TRANSFERÊNCIAS 61 Crossref CITAÇÕES Google
Scholar CITAÇÕES

Artigos com conteúdo semelhante:

Androgen Receptor: An Overview Critical Reviews™ in Eukaryotic Gene Expression, Vol.5, 1995, issue 2
Alan Saltzman, Chihuei Wang, Han-Jung Lee, Shuyuan Yeh, Winjing Young, Chawnshang Chang, Atsushi Mizokami, Evan T. Keller
IAPs: Mediators of Oncogenesis and Targets for Anticancer Therapy Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 5-6
Ali Bettaieb, Stéphanie Plenchette, Laurence Dubrez, Sarra Bouaouiche
Resistance to Cell Death and Its Modulation in Cancer Stem Cells Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Ahmad R. Safa
Chemokines and Chemokine Receptors as Promoters of Prostate Cancer Growth and Progression Critical Reviews™ in Eukaryotic Gene Expression, Vol.23, 2013, issue 1
Nicole Salazar, Miguel Castellan, Bal L. Lokeshwar, Samir S. Shirodkar
The Proteasome and Its Inhibitors in Immune Regulation and Immune Disorders Critical Reviews™ in Immunology, Vol.26, 2006, issue 6
Alberto Ballestrero, Franco Patrone, Frank Grunebach, Alessio Nencioni, Peter Brossart

Última edição

SIAH2-Mediated Degradation of ACSL4 Inhibits the Anti-Tumor Activity of CD8+ T Cells in Hepatocellular Carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer Ruixue Wang, Wenhua Tan SLC7A2-Mediated Lysine Catabolism Inhibits Immunosuppression in Triple Negative Breast Cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH1 Promotes the Pyroptosis of Cardiomyocytes in Diabetic Cardiomyopathy via Regulating IκB-α/NF-κВ Signaling Jinbin Wu, Yaoming Yan PURPL Promotes M2 Macrophage Polarization in Lung Cancer by Regulating RBM4/xCT Signaling Jipeng Guo, Chongwen Gong, Hao Wang

Próximos artigos

Fundamentals and translational applications of stem cells and biomaterials in dental, oral and craniofacial regenerative medicine Yasaman Daneshian, Eric Lewallen, Amr Badreldin, Allan Dietz , Gary Stein, Simon Cool, Hyun-Mo Ryoo, Young Dan Cho, Andre van Wijnen Inflammatory Markers Involved in the Pathogenesis of Dupuytren Contracture William Cates, Janet Denbeigh, Ralph Salvagno, Sanjeev Kakar, Andre van Wijnen, Charles Eaton PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain